{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:26:51Z","timestamp":1684470411348},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T00:00:00Z","timestamp":1217289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/sj.bjc.6604512","type":"journal-article","created":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T21:40:31Z","timestamp":1217367631000},"page":"488-490","source":"Crossref","is-referenced-by-count":11,"title":["The transforming mutation E17K\/AKT1 is not a major event in B-cell-derived lymphoid leukaemias"],"prefix":"10.1038","volume":"99","author":[{"given":"I S","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Sughayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H A","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Eshtayeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S","family":"Awidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M S","family":"EL-Khateeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S I","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,29]]},"reference":[{"key":"BF6604512_CR1","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","volume":"24","author":"DA Altomare","year":"2005","unstructured":"Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455\u20137464","journal-title":"Oncogene"},{"key":"BF6604512_CR2","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1182\/blood.V99.8.2969","volume":"99","author":"M Barrag\u00e1n","year":"2002","unstructured":"Barrag\u00e1n M, Bellosillo B, Camp\u00e0s C, Colomer D, Pons G, Gil J (2002) Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 99: 2969\u20132976","journal-title":"Blood"},{"key":"BF6604512_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1189\/jlb.0106041","volume":"80","author":"M Barrag\u00e1n","year":"2006","unstructured":"Barrag\u00e1n M, de Frias M, Iglesias-Serret D, Camp\u00e0s C, Casta\u00f1o E, Santidri\u00e1n AF, Coll-Mulet L, Cosialls AM, Domingo A, Pons G, Gil J (2006) Regulation of Akt\/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C\u03b2. J Leukoc Biol 80: 1473\u20131479","journal-title":"J Leukoc Biol"},{"key":"BF6604512_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","volume":"94","author":"A Bellacosa","year":"2005","unstructured":"Bellacosa A, Kumar CC, Di Cristofano A, Testa JR (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 94: 29\u201386","journal-title":"Adv Cancer Res"},{"key":"BF6604512_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature05933","volume":"448","author":"JD Carpten","year":"2007","unstructured":"Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448: 439\u2013444","journal-title":"Nature"},{"key":"BF6604512_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000108315","volume":"118","author":"FE Cotter","year":"2007","unstructured":"Cotter FE, Auer RL (2007) Genetic alteration associated with chronic lymphocytic leukemia. Cytogenet Genome Res 118: 310\u2013319","journal-title":"Cytogenet Genome Res"},{"key":"BF6604512_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","volume":"18","author":"S Cun\u00ed","year":"2004","unstructured":"Cun\u00ed S, P\u00e9rez-Aciego P, P\u00e9rez-Chac\u00f3n G, Vargas JA, S\u00e1nchez A, Mart\u00edn-Saavedra FM, Ballester S, Garc\u00eda-Marco J, Jord\u00e1 J, Dur\u00e1ntez A (2004) A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 18: 1391\u20131400","journal-title":"Leukemia"},{"key":"BF6604512_CR8","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","volume":"64","author":"RL Elstrom","year":"2004","unstructured":"Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB (2004) Akt stimulates aerobic glycolysis in cancer. Cancer Res 64: 3892\u20133899","journal-title":"Cancer Res"},{"key":"BF6604512_CR9","first-page":"3","volume":"1697","author":"M Hanada","year":"2004","unstructured":"Hanada M, Feng J, Hemmings B (2004) Structure, regulation and function of PKB\/AKT \u2013 a major therapeutic target. Biochem Biophys Acta 1697: 3\u201316","journal-title":"Biochem Biophys Acta"},{"key":"BF6604512_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.anndiagpath.2007.08.002","volume":"11","author":"KV Inamdar","year":"2007","unstructured":"Inamdar KV, Bueso-Ramos CE (2007) Pathology of chronic lymphocytic leukemia: an update. Ann Diagn Pathol 11: 363\u2013389","journal-title":"Ann Diagn Pathol"},{"key":"BF6604512_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.bjc.6604212","volume":"98","author":"MS Kim","year":"2008","unstructured":"Kim MS, Jeong EG, Yoo NJ, Lee SH (2008) Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. Br J Cancer 98: 1533\u20131535","journal-title":"Br J Cancer"},{"key":"BF6604512_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2404417","volume":"21","author":"PG Longo","year":"2007","unstructured":"Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P, Sica S, Leone G, Efremov DG (2007) The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 21: 110\u2013120","journal-title":"Leukemia"},{"key":"BF6604512_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","volume":"111","author":"PG Longo","year":"2008","unstructured":"Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG (2008) The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 111: 846\u2013855","journal-title":"Blood"},{"key":"BF6604512_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4161\/cc.7.5.5485","volume":"7","author":"D Malanga","year":"2008","unstructured":"Malanga D, Scrima M, De Marco C, Fabiani F, De Rosa N, de Gisi S, Malara N, Savino R, Rocco G, Chiappetta G, Franco R, Tirino V, Pirozzi G, Viglietto G (2008) Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung. Cell Cycle 7: 665\u2013669","journal-title":"Cell Cycle"},{"key":"BF6604512_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129: 1261\u20131274","journal-title":"Cell"},{"key":"BF6604512_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","volume":"14","author":"KM Nicholson","year":"2002","unstructured":"Nicholson KM, Anderson NG (2002) The protein kinase B\/Akt signaling pathway in human malignancy. Cell Signal 14: 381\u2013395","journal-title":"Cell Signal"},{"key":"BF6604512_CR17","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1182\/blood-2004-07-2669","volume":"105","author":"A Petlickovski","year":"2005","unstructured":"Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG (2005) Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood 105: 4820\u20134827","journal-title":"Blood"},{"key":"BF6604512_CR18","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1038\/sj.onc.1209097","volume":"24","author":"DR Plas","year":"2005","unstructured":"Plas DR, Thompson CB (2005) Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24: 7435\u20137442","journal-title":"Oncogene"},{"key":"BF6604512_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219\u2013234","journal-title":"Blood"},{"key":"BF6604512_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10555-005-1577-9","volume":"24","author":"GP Robertson","year":"2005","unstructured":"Robertson GP (2005) Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev 24: 273\u2013285","journal-title":"Cancer Metastasis Rev"},{"key":"BF6604512_CR21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1080\/1042819021000003009","volume":"43","author":"S Sarkar","year":"2002","unstructured":"Sarkar S, Svoboda M, de Beaumont R, Freedman AS (2002) The role of Akt and RAFTK in beta1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells. Leuk Lymphoma 43: 1663\u20131671","journal-title":"Leuk Lymphoma"},{"key":"BF6604512_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00401-007-0334-2","volume":"115","author":"U Sch\u00fcller","year":"2008","unstructured":"Sch\u00fcller U, Ruiter M, Herms J, Kretzschmar HA, Grasbon-Frodl E (2008) Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas. Acta Neuropathol 115: 367\u2013368","journal-title":"Acta Neuropathol"},{"key":"BF6604512_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000096289","volume":"70","author":"YH Soung","year":"2006","unstructured":"Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ, Lee SH (2006) Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology 70: 285\u2013289","journal-title":"Oncology"},{"key":"BF6604512_CR24","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1073\/pnas.74.7.3065","volume":"74","author":"SP Staal","year":"1977","unstructured":"Staal SP, Hartley JW, Rowe W (1977) Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci USA 74: 3065\u20133067","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6604512_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1084\/jem.167.3.1259","volume":"167","author":"SP Staal","year":"1988","unstructured":"Staal SP, Hartley JW (1988) Thymic lymphoma induction by the AKT8 murine retrovirus. J Exp Med 167: 1259\u20131264","journal-title":"J Exp Med"},{"key":"BF6604512_CR26","doi-asserted-by":"publisher","first-page":"10983","DOI":"10.1073\/pnas.211430998","volume":"98","author":"JR Testa","year":"2001","unstructured":"Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98: 10983\u201310985","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6604512_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2141.2007.06920.x","volume":"140","author":"R Tibes","year":"2008","unstructured":"Tibes R, Kornblau SM, Qiu Y, Mousses SM, Robbins C, Moses T, Carpten JD (2008) PI3K\/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation. Br J Haematol 140: 344\u2013347","journal-title":"Br J Haematol"},{"key":"BF6604512_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.leukres.2003.10.033","volume":"28","author":"L Wang","year":"2004","unstructured":"Wang L, Fortney JE, Gibson LF (2004) Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leuk Res 28: 733\u2013742","journal-title":"Leuk Res"},{"key":"BF6604512_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07113.x","volume":"141","author":"T Zenz","year":"2008","unstructured":"Zenz T, D\u00f6hner K, Denzel T, D\u00f6hner H, Stilgenbauer S, Bullinger L (2008) Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations. Br J Haematol 141: 742\u2013743","journal-title":"Br J Haematol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604512","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:34:25Z","timestamp":1684413265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,29]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BF6604512"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604512","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,29]]}}}